Literature DB >> 27225918

[Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].

Laurent Genser1, Christine Poitou2, Édith Brot-Laroche3, Monique Rousset3, Jean-Christophe Vaillant4, Karine Clément2, Sophie Thenet3, Armelle Leturque3.   

Abstract

The increasing incidence of obesity and associated metabolic complications is a worldwide public health issue. The role of the gut in the pathophysiology of obesity, with an important part for microbiota, is becoming obvious. In rodent models of diet-induced obesity, the modifications of gut microbiota are associated with an alteration of the intestinal permeability increasing the passage of food or bacterial antigens, which contribute to low-grade inflammation and insulin resistance. In human obesity, intestinal permeability modification, and its role in the crosstalk between gut microbiota changes and inflammation at systemic and tissular levels, are still poorly documented. Hence, further characterization of the triggering mechanisms of such inflammatory responses in obese subjects could enable the development of personalized intervention strategies that will help to reduce the risk of obesity-associated diseases.
© 2016 médecine/sciences – Inserm.

Entities:  

Mesh:

Year:  2016        PMID: 27225918     DOI: 10.1051/medsci/20163205012

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  4 in total

1.  Sleeve Gastrectomy Alters Intestinal Permeability in Diet-Induced Obese Mice.

Authors:  Claire Blanchard; François Moreau; Julien Chevalier; Audrey Ayer; Damien Garcon; Lucie Arnaud; Jean-Paul Pais de Barros; Thomas Gautier; Michel Neunlist; Bertrand Cariou; Cédric Le May
Journal:  Obes Surg       Date:  2017-10       Impact factor: 4.129

2.  Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model.

Authors:  Xiaoyuan Bian; Liya Yang; Wenrui Wu; Longxian Lv; Xianwan Jiang; Qing Wang; Jingjing Wu; Yating Li; Jianzhong Ye; Daiqiong Fang; Ding Shi; Kaicen Wang; Qiangqiang Wang; Yanmeng Lu; Jiaojiao Xie; Jiafeng Xia; Lanjuan Li
Journal:  Microb Biotechnol       Date:  2020-05-03       Impact factor: 5.813

Review 3.  The Neuroimmune Role of Intestinal Microbiota in the Pathogenesis of Cardiovascular Disease.

Authors:  Andrey V Suslov; Elizaveta Chairkina; Maria D Shepetovskaya; Irina S Suslova; Victoria A Khotina; Tatiana V Kirichenko; Anton Y Postnov
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

4.  Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice.

Authors:  Hui-Lu Zhang; Wen-Shuai Li; Dian-Nan Xu; Wan-Wei Zheng; Yi Liu; Jian Chen; Zhi-Bing Qiu; Robert G Dorfman; Jun Zhang; Jie Liu
Journal:  Exp Ther Med       Date:  2016-09-08       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.